New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 2, 2013
10:02 EDTHAIN, URBN, QDEL, ZEUS, BC, TTM, CAT, VAL, X, POM, MAR, OSK, ADM, WAG, SFD, PRXL, BCR, ITWOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Brunswick (BC) upgraded to Outperform from Market Perform at BMO Capital... C.R. Bard (BCR) upgraded to Overweight from Neutral at JPMorgan... Marriott (MAR) upgraded to Buy from Neutral at SunTrust... Olympic Steel (ZEUS) upgraded to Neutral from Underperform at Credit Suisse... PAREXEL (PRXL) upgraded to Buy from Neutral at Citigroup... Pepco Holdings (POM) upgraded to Outperform from Market Perform at Wells Fargo... Quidel (QDEL) upgraded to Outperform from Market Perform at Raymond James... Smithfield Foods (SFD) upgraded to Outperform from Market Perform at BMO Capital... U.S. Steel (X) upgraded to Outperform from Neutral at Credit Suisse... Urban Outfitters (URBN) upgraded to Hold from Underperform at Jefferies... Valspar (VAL) upgraded to Buy from Hold at KeyBanc... Walgreen (WAG) upgraded to Outperform from Market Perform at Raymond James... Hain Celestial (HAIN) upgraded to Outperform from Market Perform at BMO Capital... Archer Daniels (ADM) upgraded to Buy from Hold at Miller Tabak... Caterpillar (CAT) upgraded to Buy from Neutral at ISI Group... Illinois Tool Works (ITW) upgraded to Buy from Neutral at ISI Group... Oshkosh (OSK) upgraded to Buy from Neutral at ISI Group... Tata Motors (TTM) upgraded to Buy from Neutral at BofA/Merrill.
News For BC;BCR;MAR;ZEUS;PRXL;POM;QDEL;SFD;X;URBN;WAG;VAL;HAIN;ADM;CAT;ITW;OSK;TTM From The Last 14 Days
Check below for free stories on BC;BCR;MAR;ZEUS;PRXL;POM;QDEL;SFD;X;URBN;WAG;VAL;HAIN;ADM;CAT;ITW;OSK;TTM the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
April 10, 2014
13:47 EDTOSKOshkosh Defense segment to lay off approximately 700 hourly workers
Subscribe for More Information
11:28 EDTWAGWalgreens management to meet with BB&T
Subscribe for More Information
11:23 EDTWAGRite Aid hits 52-week high after results, sales view top estimates
Shares of retail drugstore Rite Aid (RAD) are rallying after the company's fourth quarter results and fiscal 2015 revenue outlook topped analysts' consensus estimates. WHAT'S NEW: This morning, Rite Aid reported fourth quarter adjusted earnings per share of 10c and revenue of $6.6B, compared to expectations of 4c and $6.54B, respectively. Q4 same store sales increased 2.1%. Rite Aid forecast FY15 EPS of 31c-42c, compared to the consensus of 35c. FY15 revenue was seen at $26B-$26.5B, ahead of the consensus $25.75B. FY15 same-store sales are expected by the company to be up 2.5%-4.5%. WHAT'S NOTABLE: Rite Aid also announced it has acquired RediClinic, which currently operates 30 clinics in the greater Houston, Austin and San Antonio areas. Rite Aid CEO John Standley said, “Our recent acquisitions of Health Dialog and RediClinic, our expanded partnership with McKesson and our continued commitment to investing in our store base have positioned us to transition our strategy from turnaround to growth as we more aggressively pursue opportunities to become a growing retail healthcare company.” PRICE ACTION: In late morning trading, Rite Aid rose 71c, or about 11%, to $7.11 on more than twice its average daily trading volume. Earlier in the session, the stock hit a fresh 52-week high of $7.39. Including today's advance, the stock is up approximately 300% over the past twelve months. OTHERS TO WATCH: Other retail drugstore operators include Walgreen Company (WAG) and CVS Caremark (CVS).
April 9, 2014
12:04 EDTADMU.S. corn exports projected to increase 125M bushels
Subscribe for More Information
10:02 EDTXBofA/Merrill's US autos/auto parts analyst has analyst/industry conference call
Subscribe for More Information
09:33 EDTCATBofA/Merrill's industrial/mining analysts hold analyst/industry conference call
Subscribe for More Information
08:05 EDTURBNUrban Outfitters long-term outlook positive, says Wedbush
Subscribe for More Information
07:48 EDTXBofA/Merrill's steel analysts hold an analyst/industry conference call
Subscribe for More Information
07:37 EDTBCBrunswick should be bought after negative Q1 preannouncement, says Wells Fargo
Subscribe for More Information
April 8, 2014
09:32 EDTBCHouse Ways & Means Committee to hold a hearing
The Committee holds a hearing entitled, "The Benefits of Permanent Tax Policy for America’s Job Creators" with VP Zelisko of Brunswick Corporation (BC) on April 8 at 10 am. Webcast Link
08:20 EDTBCBrunswick reaffirms FY14 EPS view of $2.40-$2.55, consensus $2.54
08:19 EDTBCBrunswick reports preliminary Q1 EPS 59c-60c, consensus 66c
Brunswick chairman and CEO Dustan E. McCoy stated, "Weather conditions in important marine markets had a negative impact on Q1 U.S. retail and wholesale demand. The severity of the weather patterns has not only reduced sales, but it has also masked the underlying demand for our boat and engine products."
07:35 EDTBCRNeedham to hold a conference
Life Sciences Conference is being held in New York on April 8-9.
April 7, 2014
10:00 EDTOSKOn The Fly: Analyst Initiation Summary
Subscribe for More Information
10:00 EDTBCROn The Fly: Analyst Downgrade Summary
Subscribe for More Information
08:15 EDTMARMarriott sees opening 30 new South African hotels, Reuters reports
Marriott, which aims to triple its revenue and rooms across Africa and the Middle East within six years, plans to open 30 new hotels in South Africa by 2020, reported Reuters, citing Marriott's Middle East and Africa head Alex Kyriakidis. Reference Link
07:58 EDTBCRMedtronic data positive for C.R. Bard, says Barclays
Barclays said Medtronic's (MDT) better than expected drug coated balloon data could have a positive class effect that benefits C.R. Bard (BCR). The firm reiterates its Overweight rating C.R. Bard and raised its price target to $165 from $160. Note that BofA/Merrill downgraded C.R. Bard to Neutral from Buy following the Medtronic's news.
07:38 EDTBCRMedtronic data should lead to approval of drug-coated balloon, says Wells Fargo
Subscribe for More Information
07:26 EDTBCRC.R. Bard downgraded to Neutral from Buy at BofA/Merrill
Subscribe for More Information
07:16 EDTOSKOshkosh initiated with a Neutral at Citigroup
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use